grant

Nervous system control and regulation of the immune system following neurological insults

Organization DUKE UNIVERSITYLocation DURHAM, UNITED STATESPosted 15 Aug 2021Deadline 31 Jul 2026
NIHUS FederalResearch GrantFY20250-11 years old21+ years oldAIDSAcquired Immune DeficiencyAcquired Immune Deficiency SyndromeAcquired Immunodeficiency SyndromeAcquired brain injuryAcuteAdultAdult HumanAffectAntigensApoplexyAtrophicAtrophyAutoregulationBiochemicalBlood SerumBone MarrowBone Marrow GraftingBone Marrow Reticuloendothelial SystemBone Marrow TransplantBone Marrow TransplantationBrainBrain CancerBrain InjuriesBrain Nervous SystemBrain TraumaBrain Vascular AccidentCD4 CellsCD4 Positive T LymphocytesCD4 T cellsCD4 helper T cellCD4 lymphocyteCD4+ T-LymphocyteCD4-Positive LymphocytesCNS CancerCNS InjuryCNS Nervous SystemCNS TumorCNS neoplasmCancer InductionCausalityCell BodyCell CountCell NumberCellsCentral Nervous SystemCentral Nervous System CancerCentral Nervous System NeoplasmsCentral Nervous System TumorsCentral Nervous System Viral DiseasesCentral Nervous System Viral InfectionsCerebral StrokeCerebrovascular ApoplexyCerebrovascular StrokeChemical FractionationChemicalsChildChild YouthChildren (0-21)ChronicClinicDataDefectDenervationEncephalonEnsureEtiologyFRACNFailureFractionationFractionation RadiotherapyGlial Cell TumorsGlial NeoplasmGlial TumorGlioblastomaGliomaGoalsGrade IV Astrocytic NeoplasmGrade IV Astrocytic TumorGrade IV AstrocytomaHealthHomeostasisHospitalsImmuneImmune Modulation TherapyImmune mediated therapyImmune responseImmune systemImmunesImmunityImmunochemical ImmunologicImmunologicImmunologic ModelImmunologicalImmunological ModelsImmunologicallyImmunologically Directed TherapyImmunologicsImmunomodulationImmunosuppressionImmunosuppression EffectImmunosuppressive EffectImmunotherapyInflammationInjuryMalignant CNS NeoplasmsMalignant Tumor of the BrainMalignant Tumor of the CNSMalignant Tumor of the Central Nervous SystemMalignant neoplasm of brainMalignant neoplasm of central nervous systemMapsMarrow TransplantationMass Photometry/Spectrum AnalysisMass SpectrometryMass SpectroscopyMass SpectrumMass Spectrum AnalysesMass Spectrum AnalysisMediatingModelingMolecularMolecular WeightMorbidityMorbidity - disease rateNerve CellsNerve UnitNervous SystemNervous System DiseasesNervous System DisorderNervous System InjuriesNervous System TraumaNervous System controlNervous System damageNeural CellNeuraxisNeurocyteNeuroglial NeoplasmNeuroglial TumorNeuroimmuneNeurologicNeurologic Body SystemNeurologic DisordersNeurologic ModelsNeurologic Organ SystemNeurologicalNeurological DamageNeurological DisordersNeurological InjuryNeurological ModelsNeurological traumaNeurologyNeuronsOpportunistic InfectionsOrganParabiosisPathway interactionsPatientsPeripheralPhysiological HomeostasisProteinsPublishingRabies mappingRabies trans synaptic tracingRabies virus mediated mappingResearchRoleSeizuresSerumSpleenSpleen Reticuloendothelial SystemSterilityStrokeSystems DevelopmentT cell reconstitutionT memory cellT-Cell DevelopmentT-Cell OntogenyT-CellsT-LymphocyteT-Lymphocyte DevelopmentT4 CellsT4 LymphocytesTestingThymusThymus GlandThymus ProperThymus Reticuloendothelial SystemTimeTraumatic Brain InjuryViral CNS InfectionsViral EncephalitisViral Infectious EncephalomyelitisWorkadulthoodanti-tumor immune responsebrain attackbrain damagebrain-injuredcancer of the central nervous systemcarcinogenesiscausationcentral nervous system injurycerebral vascular accidentcerebrovascular accidentclinical relevanceclinically relevantcohortcombatdisease causationenthusiastic atmosphereenthusiastic environmentglial-derived tumorglioblastoma multiformehost responsehypoimmunityimmune deficiencyimmune modulationimmune modulatory therapiesimmune modulatory treatmentimmune regulationimmune regulation therapyimmune regulation treatmentimmune regulatory therapyimmune suppressionimmune suppressive activityimmune suppressive functionimmune system responseimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmune-modulation treatmentimmuno therapyimmunodeficiencyimmunogenimmunologic reactivity controlimmunomodulation therapyimmunomodulation treatmentimmunomodulator therapiesimmunomodulator treatmentimmunomodulator-based therapiesimmunomodulatoryimmunomodulatory biologicsimmunomodulatory therapiesimmunomodulatory treatmentimmunoneurologyimmunoregulationimmunoregulatoryimmunoregulatory therapyimmunoregulatory treatmentimmunoresponseimmunosuppressive activityimmunosuppressive functionimmunosuppressive responsein vitro Assayinjured CNSinjuriesinnervationkidsmemory T lymphocytemortalitynerve supplyneuroglia neoplasmneuroglia tumorneuroimmunologyneurological diseaseneuronalneurotraumanew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapypathwayprimary lymphatic organprimary lymphoid organprogramsrabies based mappingrabies based retrograde mappingrabies circuit tracingrabies mediated retrograde monosynaptic tracingrabies retrograde tracingrabies tracerrabies tracingrabies viral tracingrabies virus mediated circuit mappingrabies virus monosynaptic circuit tracingrabies virus monosynaptic tracingrabies virus neurotracerrabies virus retrograde tracingrabies virus tracingresponsesocial rolespongioblastoma multiformesterilestroke patientstrokedstrokessuccesssupportive atmospheresupportive environmenttherapeutic immunomodulationtherapeutic immunoregulationthymus derived lymphocytethymus transplantationtracing with rabiestraumatic brain damagetumor of the central nervous systemtumors in the central nervous systemyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Suppression of the immune system following damage to the central nervous system (CNS) is a common feature of neurological diseases as diverse as stroke, traumatic brain injury (TBI), and glioblastoma (GBM). This immunosuppression causes mortality and leads to the failure of immune-modulating therapies. The underlying mechanisms of systemic immunosuppression following neurological insults remain largely unknown. In this proposal, we focus on the thymus, the primary immune organ responsible for T cell development in children and adults.

We tested thymic function following various neurological insults, including viral infections of the CNS, tumors, sterile inflammation, physical injury, and seizure activity. All insults resulted in significant thymic involution that was reversible upon clearance of the injury. Importantly, thymic involution did not occur following peripheral insults. Using parabiosis, we found that thymic involution was transferable from glioma- bearing to non-tumor-bearing parabionts demonstrating the crucial role of serum-derived soluble factors in mediating thymic involution.

Specifically, serum-derived molecules with molecular weights (MW) larger than 300 kDa were deemed immunosuppressive. Interestingly, the thymus is heavily innervated by the CNS, yet the role of this innervation during neurological injuries and immunosuppression remains unknown. We demonstrated, for the first time, that the thymus is heavily innervated by both extrinsic neurons (cell bodies outside of the thymus), and intrinsic neurons (cell bodies within the thymus) using rabies virus neurotracers. In short, the multifaceted immunosuppression following neurological insults alters immune homeostasis in the thymus, bone marrow, and the spleen.

The extents to which these alterations in the immune organs induce transient or long-lasting immunological defects remain understudied. Thymic involution, presence of immunosuppressive factors in serum, changes within the bone marrow niche, and long-lasting immunological defects together account, at least in part, for immune deficiencies observed following neurologic injuries. Based on these data, we hypothesized that following neurological insults the brain suppresses the immune system both systemically and locally through soluble factors and innervation. This in turn alters the immune repertoire and affects long-term immunity.

This hypothesis will be tested in the following three aims: Aim1: To determine the molecular identity of serum-derived immunosuppressive factors during neurological insults; Aim 2: To determine the function of thymic innervation at baseline and during neurological insults; Aim 3: To determine transient and long-lasting functional consequences of immunosuppression on the immune system following neurological injuries. Successful completion of these aims will significantly impact understanding of immunosuppression and nervous control of the immune system during neurological injuries and will help us develop new therapeutics to combat immunosuppression in a large cohort of patients with acute and chronic neurological traumas.

Grant Number: 5R00NS117799-05
NIH Institute/Center: NIH

Principal Investigator: Katayoun Ayasoufi

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →